Andrew J. Fromkin's Net Worth
$3.88 Million
Who is Andrew J. Fromkin?
Andrew J. Fromkin has an estimated net worth of $3.88 Million. This is based on reported shares across multiple companies, which include Radius Health, Inc., Immunovant, Inc., Regado Biosciences Inc, and CLINICAL DATA INC.
SEC CIK
Andrew J. Fromkin's CIK is 0001341896
Past Insider Trading and Trends
2007 was Andrew J. Fromkin's most active year for acquiring shares with 7 total transactions. Andrew J. Fromkin's most active month to acquire stocks was the month of November. 2011 was Andrew J. Fromkin's most active year for disposing of shares, totalling 10 transactions. Andrew J. Fromkin's most active month to dispose stocks was the month of March. 2013 saw Andrew J. Fromkin paying a total of $8,373,608.85 for 2,427,133 shares, this is the most they've acquired in one year. In 2011 Andrew J. Fromkin cashed out on 1,089,133 shares for a total of $17,829,500.84, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Radius Health, Inc. No price found
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Immunovant, Inc. (IMVT) Snapshot price: $37.16
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +12.69% | 11.26K |
—
|
—
| 99.91K |
Apr 2
| |||
Form 4
| -12.23% | -12.35K |
$39.73 | -$490,696.72 | 88.66K |
Scheduled
|
Dec 1
| ||
Form 4
| +14.15% | 12.52K |
—
|
—
| 101.01K |
Apr 12
| |||
Form 4
| +31.23% | 21.06K |
—
|
—
| 88.48K |
Aug 17
| |||
Form 4
| +47.54% | 21.73K |
—
|
—
| 67.43K |
Jan 10
| |||
Form 4
| +13.68% | 5.5K |
$7.90 | $43,450.00 | 45.7K |
Aug 10
| |||
Form 4
| +62.75% | 15.5K |
—
|
—
| 40.2K |
Mar 19
| |||
Form 4
|
∞
| 24.7K |
—
|
—
| 24.7K |
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Regado Biosciences Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CLINICAL DATA INC No price found
CEO, President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -9.40K |
$30.00 | -$282,150.00 |
0
|
Apr 12 - Apr 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 22
| |||
Form 4
| +27.01% | 2K |
$9.56 | $19,129.60 | 9.4K |
Nov 12
| |||
Form 4
| +37.00% | 2K |
$15.00 | $30,000.00 | 7.41K |
Sep 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 17
| |||
Form 4/A
| +53.33% | 1.88K |
$22.84 | $42,931.00 | 5.41K |
Dec 12
| |||
Form 4
| +80.00% | 1.88K |
$22.84 | $42,931.00 | 4.23K |
Dec 12
| |||
Form 4
| +104.35% | 1.2K |
$26.70 | $32,034.00 | 2.35K |
Sep 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
| +130.00% | 650 |
$16.67 | $10,836.67 | 1.15K |
Dec 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 21
| |||
Form 4/A
|
∞
| 500 |
$11.90 | $5,950.00 | 500 |
Aug 21
| |||
Form 4
|
∞
| 500 |
$11.90 | $5,950.00 | 500 |
Aug 21
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||